Reviva Pharmaceuticals Holdings common stock delisted from Nasdaq
Nasdaq removed Reviva Pharmaceuticals Holdings' common stock from listing on July 10, 2026, under Rule 12d2-2(b) for failure to meet continued-listing standards. The delisting was initiated by the exchange.
Key facts
- Common stock delisted from Nasdaq Stock Market LLC on July 10, 2026
- Removal basis: Rule 17 CFR 240.12d2-2(b) — failure to meet continued-listing standards
- Exchange-initiated delisting, not orderly merger or disposition
Why it matters
Reviva Pharmaceuticals' securities no longer trade on Nasdaq and are subject to deregistration under Section 12(b), significantly limiting liquidity and accessibility for shareholders.
Share
Derived from 25-NSE filed 2026-07-10. Not investment advice. View the source filing on SEC.gov →